BioLight to Present at the Canaccord Genuity 2014 Medical Technology and Diagnostics Forum
TEL AVIV, Israel, October 22, 2014 /PRNewswire/ --
BioLight Life Sciences Investments Ltd. (TASE: BOLT, OTCQX:BLGTY), a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announced today that Suzana Nahum-Zilberberg, CEO, and Itai Bar Natan, CFO, will present at the Canaccord Genuity Medical Technology and Diagnostics Forum at the Westin Grand Central in New York, NY.
The BioLight presentation is scheduled to start at 4 p.m. ET on Thursday, November 20, 2014. Mrs. Nahum-Zilberberg and Mr. Bar Natan will also be available to participate in one-on-one meetings with investors who are registered to attend the conference.
